BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10365829)

  • 1. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
    Eskelinen MJ; Haglund UH
    Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of prognostic factors in human pancreatic adenocarcinoma.
    Eskelinen M; Lipponen P
    Cancer Detect Prev; 1992; 16(5-6):287-95. PubMed ID: 1335360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Precursors to pancreatic cancer].
    Søreide K; Immervoll H; Molven A
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of pancreatic cancer.
    Inoue S; Tezel E; Nakao A
    Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
    Sakorafas GH; Tsiotou AG; Tsiotos GG
    Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
    Bardeesy N; Sharpless NE; DePinho RA; Merlino G
    Semin Cancer Biol; 2001 Jun; 11(3):201-18. PubMed ID: 11407945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of pancreatic cancer.
    Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
    Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular prognostic markers in pancreatic cancer.
    Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
    J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.
    Dong M; Nio Y; Tamura K; Song MM; Guo KJ; Guo RX; Dong YT
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):279-84. PubMed ID: 10750666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular pathways of pancreatic carcinogenesis].
    Torrisani J; Buscail L
    Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer: epidemiology and risk factors.
    Krejs GJ
    Dig Dis; 2010; 28(2):355-8. PubMed ID: 20814212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic basis of pancreatic adenocarcinoma.
    Hilgers W; Kern SE
    Genes Chromosomes Cancer; 1999 Sep; 26(1):1-12. PubMed ID: 10440999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer: a plea for good and comprehensive morphological studies.
    Algül H; Schmid RM
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):713-5. PubMed ID: 18617774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-step pancreatic carcinogenesis and its clinical implications.
    Sakorafas GH; Tsiotou AG
    Eur J Surg Oncol; 1999 Dec; 25(6):562-5. PubMed ID: 10555999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
    Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
    Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.